142
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Nondiabetic Glucometabolic Status and Aortic Stiffness in Community Hypertension Patients

ORCID Icon, , &
Pages 591-600 | Published online: 25 Feb 2022

References

  • Onuh JO, Qiu H. New progress on the study of aortic stiffness in age-related hypertension. J Hypertens. 2020;38(10):1871–1877. doi:10.1097/HJH.0000000000002452
  • Cardoso CRL, Salles GC, Salles GF. Prognostic impact of aortic stiffness in patients with resistant hypertension. Hypertension. 2019;73(3):728–735. doi:10.1161/HYPERTENSIONAHA.118.12367
  • Bruno RM, Cartoni G, Stea F, et al. Carotid and aortic stiffness in essential hypertension and their relation with target organ damage: the CATOD study. J Hypertens. 2017;35(2):310–318. doi:10.1097/HJH.0000000000001167
  • Gnakamene JB, Safar ME, Levy BI, Escoubet B. Left ventricular torsion associated with aortic stiffness in hypertension. J Am Heart Assoc. 2018;7(5). doi:10.1161/JAHA.117.007427
  • Johansen NB, Charles M, Vistisen D, et al. Effect of intensive multifactorial treatment compared with routine care on aortic stiffness and central blood pressure among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care. 2012;35(11):2207–2214. doi:10.2337/dc12-0176
  • Chirinos JA, Segers P, Gillebert TC, et al. Central pulse pressure and its hemodynamic determinants in middle-aged adults with impaired fasting glucose and diabetes: the Asklepios study. Diabetes Care. 2013;36(8):2359–2365. doi:10.2337/dc12-1463
  • McEniery CM, Wilkinson IB, Johansen NB, et al. Nondiabetic glucometabolic status and progression of aortic stiffness: the Whitehall II Study. Diabetes Care. 2017;40(4):599–606. doi:10.2337/dc16-1773
  • Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension. 2005;46(1):232–237. doi:10.1161/01.HYP.0000164574.60279.ba
  • Xie K, Bao L, Jiang X, et al. The association of metabolic syndrome components and chronic kidney disease in patients with hypertension. Lipids Health Dis. 2019;18(1):229. doi:10.1186/s12944-019-1121-5
  • Wang A, Su Z, Liu X, et al. Brachial-ankle pulse wave velocity and metabolic syndrome in general population: the APAC study. BMC Cardiovasc Disord. 2016;16(1):228. doi:10.1186/s12872-016-0409-x
  • Nakanishi N, Shiraishi T, Wada M. Brachial-ankle pulse wave velocity and metabolic syndrome in a Japanese population: the Minoh study. Hypertens Res. 2005;28(2):125–131. doi:10.1291/hypres.28.125
  • Liu LS. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.
  • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–470. doi:10.7326/0003-4819-130-6-199903160-00002
  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
  • Perticone M, Maio R, Tassone EJ, et al. Insulin-resistance HCV infection-related affects vascular stiffness in normotensives. Atherosclerosis. 2015;238(1):108–112. doi:10.1016/j.atherosclerosis.2014.11.025
  • Chen CH, Ting CT, Nussbacher A, et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension. 1996;27(2):168–175. doi:10.1161/01.HYP.27.2.168
  • Covic A, Siriopol D. Pulse wave velocity ratio: the new “gold standard” for measuring arterial stiffness. Hypertension. 2015;65(2):289–290. doi:10.1161/HYPERTENSIONAHA.114.04678
  • Tanaka A, Tomiyama H, Maruhashi T, et al. Physiological diagnostic criteria for vascular failure. Hypertension. 2018;72(5):1060–1071. doi:10.1161/HYPERTENSIONAHA.118.11554
  • Kozakova M, Morizzo C, Fraser AG, Palombo C. Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus. Cardiovasc Diabetol. 2017;16(1):78. doi:10.1186/s12933-017-0557-z
  • Nam JS, Park JS, Cho MH, et al. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG. Diabetes Res Clin Pract. 2009;84(2):145–151. doi:10.1016/j.diabres.2009.02.002
  • Tomiyama H, Vlachopoulos C, Xaplanteris P, et al. Usefulness of the SAGE score to predict elevated values of brachial-ankle pulse wave velocity in Japanese subjects with hypertension. Hypertens Res. 2020;43(11):1284–1292. doi:10.1038/s41440-020-0472-7
  • Xaplanteris P, Vlachopoulos C, Protogerou AD, et al. A clinical score for prediction of elevated aortic stiffness: derivation and validation in 3943 hypertensive patients. J Hypertens. 2019;37(2):339–346. doi:10.1097/HJH.0000000000001904
  • Safar ME, Thomas F, Blacher J, et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol. 2006;47(1):72–75. doi:10.1016/j.jacc.2005.08.052
  • Chen L, Zhu W, Mai L, Fang L, Ying K. The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in south China. Atherosclerosis. 2015;240(2):345–350. doi:10.1016/j.atherosclerosis.2015.03.031
  • El Feghali R, Topouchian J, Pannier B, Asmar R. Ageing and blood pressure modulate the relationship between metabolic syndrome and aortic stiffness in never-treated essential hypertensive patients. A comparative study. Diabetes Metab. 2007;33(3):183–188. doi:10.1016/j.diabet.2006.11.011
  • Maloberti A, Bombelli M, Vallerio P, et al. Metabolic syndrome is related to vascular structural alterations but not to functional ones both in hypertensives and healthy subjects. Nutr Metab Cardiovasc Dis. 2021;31(4):1044–1052. doi:10.1016/j.numecd.2020.11.011
  • Maloberti A, Bruno RM, Facchetti R, et al. THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS. Eur J Intern Med. 2020;76:107–109. doi:10.1016/j.ejim.2020.02.005
  • Kolade OO, O’Moore-Sullivan TM, Stowasser M, et al. Arterial stiffness, central blood pressure and body size in health and disease. Int J Obes. 2012;36(1):93–99. doi:10.1038/ijo.2011.79
  • Mulè G, Cottone S, Mongiovì R, et al. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr Metab Cardiovasc Dis. 2006;16(1):54–59. doi:10.1016/j.numecd.2005.03.005